← Back
Treatment and the treatment process

Treatment path map

Leukemia treatment is a journey with several phases. Knowing the overall map helps you understand what to expect.

Last updated: ~2 min read
On a dark navy background, an abstract map with a gold path of light linking glowing stations from diagnosis to follow-up.
Figure 1.The treatment path runs from diagnosis to follow-up.

01Short answer

The path starts with diagnosis and classification: blood and bone marrow tests, genetic tests and setting the risk group. In acute leukemias, induction comes next — aiming for remission — followed by consolidation (intensification) to destroy remaining cells. In some cases — when risk is high or after relapse — an allogeneic stem cell transplant is planned. ALL usually includes long maintenance treatment (tablets) and prevention of central nervous system involvement; APL is treated with specific medicines. Chronic leukemias follow a different path: in CML, long-term targeted tablets with regular molecular checks; in CLL, sometimes "watch and wait", and when needed, fixed-duration or continuous treatment. Supportive care — infection prevention, transfusions, nutrition and psychological support — runs throughout, and long-term follow-up begins at the end.

02Simple explanation

The start. Diagnosis and risk group.

Main phases. Induction, consolidation and sometimes transplant.

A long road. For some types, maintenance treatment or tablets.

Afterwards. Follow-up and returning to everyday life.

03Scientific explanation

Acute leukemias: in AML, intensive induction ("7+3" or combinations with targeted drugs), then consolidation or allogeneic transplant according to risk and MRD; for people not fit for intensive treatment, gentler regimens (such as a hypomethylating agent plus venetoclax). In ALL, induction, consolidation, delayed intensification, CNS prophylaxis and maintenance for up to 2–3 years (protocol-dependent); a TKI is added in Ph+ ALL. In APL, ATRA and arsenic trioxide.

Chronic leukemias: in CML, TKI therapy with molecular response tracked against ELN milestones and, where suitable, an attempt at treatment-free remission. In CLL, treatment when indicated (iwCLL): fixed-duration BCL2 inhibitor–based regimens or continuous BTK inhibitors.

Supportive care: antimicrobial prophylaxis, transfusion, mouth care, nutrition, clot prevention, psychosocial support and, when needed, palliative care are built into every phase.

04What happens in the body?

The whole journey at a glance

The map shows the main stations from diagnosis to follow-up. At each station the team reviews results and confirms the next step.

Branches in the path

For some people the path branches toward transplant; for others it continues with chemotherapy or tablets. The choice depends on risk and response.

A teal path of light splits into two calm branches, one leading to a gold star and the other continuing straight.
Figure 2.For some, the path branches toward transplant.

Know where you are

At every phase it is normal to ask, "Where am I now and what comes next?" It reduces anxiety and helps with planning.

A single warm glowing marker on a softly lit abstract path with stations ahead and behind.
Figure 3.Knowing where you are on the path reduces anxiety.

05The main stations

A simplified outline (for acute leukemia).

Diagnosis — Tests and risk group.1DiagnosisTests and risk group.
Induction — Aiming for remission.2InductionAiming for remission.
Consolidation / transplant — Securing remission.3Consolidation / transplantSecuring remission.
Maintenance and follow-up — Long-term checks.4Maintenance and follow-upLong-term checks.
A clear pathYou know what to expect.
CheckpointsAfter each phase.
Long termMonths and years.

06The general path by leukemia type

TypeMain phasesNote
AMLInduction → consolidation or transplantGentler regimens also possible
ALLInduction → consolidation → intensification → maintenanceLong; CNS prophylaxis
APLATRA + arsenic trioxideA specific protocol
CMLTargeted tablets, molecular checksSometimes a treatment-free remission attempt
CLLWatch and wait or treatmentFixed-duration or continuous

* The exact phases and timings depend on your protocol.

07Key terms

Induction
First treatment, aiming for remission.
Consolidation
Treatment that secures remission.
Maintenance
Long, gentler treatment to prevent relapse.
Risk group
Treatment intensity based on disease features.
Watch and wait
Careful monitoring without treatment.
Treatment-free remission
Keeping remission in CML after stopping tablets.

08Key points

  • The treatment path is made of phases.
  • Results are checked after each phase.
  • The path depends on the leukemia type.
  • Not everyone needs a transplant.
  • Supportive care runs all the way.
  • Ask for your personal map in writing.

09Frequently asked questions

How long will treatment take?

It depends on the type: months in acute leukemias, years in ALL including maintenance, and often long-term in CML.

Will every phase be in hospital?

No — some phases are outpatient or at home with tablets.

Can the plan change along the way?

Yes, the plan can change with results and how you are.

How can I get this kind of map?

Ask your doctor or nurse for a written summary of your treatment plan.

10Questions for your doctor

Take these questions to your appointment. The ones you save are collected on the “My questions” page and stay on this device only.

  1. How long will treatment take?

  2. Will every phase be in hospital?

  3. Can the plan change along the way?

  4. How can I get this kind of map?

My questions

12Sources

  1. National Cancer Institute (NCI). Adult Acute Myeloid Leukemia Treatment (PDQ) – Patient Version
  2. National Cancer Institute (NCI). Adult Acute Lymphoblastic Leukemia Treatment (PDQ) – Patient Version
  3. National Cancer Institute (NCI). Chronic Myeloid Leukemia Treatment (PDQ) – Patient Version
  4. National Cancer Institute (NCI). Chronic Lymphocytic Leukemia Treatment (PDQ) – Patient Version
  5. National Cancer Institute (NCI). Types of Cancer Treatment
  6. National Cancer Institute (NCI). Follow-Up Medical Care
  7. World Health Organization. CureAll framework: WHO Global Initiative for Childhood Cancer
  8. Macmillan Cancer Support. Work and cancer: employees
  9. Leukemia & Lymphoma Society. Relapsed and refractory leukemia
  10. World Health Organization. Palliative care
Medical disclaimerThis information is for educational purposes only and does not replace medical advice.
Last updated: ← Back to the list

Open the interactive site →